Sign Up to like & get
recommendations!
0
Published in 2025 at "Drug Development Research"
DOI: 10.1002/ddr.70160
Abstract: This study evaluated the neuroprotective potential of a combination therapy using liraglutide (LIRA), an antidiabetic agent, and rivastigmine (RIVA), a standard treatment for Alzheimer's disease (AD), in a rat model of aluminum chloride (AlCl₃)‐induced AD.…
read more here.
Keywords:
rat;
combination;
lira riva;
neuroprotective effects ... See more keywords